Pacer Advisors’s Momenta Pharmaceuticals, Inc. MNTA Stock Holding History

Pacer Advisors’s Portfolio MNTA Stock Details MNTA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-3,384	Closed	-$178K	–	1558
2020 Q3	$178K	Buy	+3,384	New	+$140K	﹤0.01%	1198
2018 Q4	–	Sell	-3,278	Closed	-$86K	–	1152
2018 Q3	$86K	Buy	+3,278	New	+$88.6K	﹤0.01%	1106
2018 Q1	–	Sell	-1,750	Closed	-$24K	–	1165
2017 Q4	$24K	Buy	+1,750	New	+$23.7K	﹤0.01%	1087

Pacer Advisors's MNTA Position: Q4 2020 in Review

Pacer Advisors sold out of Momenta Pharmaceuticals, Inc. (MNTA) in Q4 2020, closing a stake of 3,384 shares — an estimated $178K sold.

Pacer Advisors first reported a position in MNTA in Q4 2017 and held it in 3 quarters. The position peaked at $178K in Q3 2020. 0 funds tracked by Wall St. Rank hold MNTA as of Q4 2020.

Pacer Advisors reported no remaining Momenta Pharmaceuticals, Inc. position as of Q4 2020 after selling out during the quarter.
Pacer Advisors sold 3,384 Momenta Pharmaceuticals, Inc. shares in Q4 2020, an estimated $178K.
Pacer Advisors first reported a position in Momenta Pharmaceuticals, Inc. in Q4 2017 and held it in 3 quarters.
Pacer Advisors's Momenta Pharmaceuticals, Inc. position peaked at $178K in Q3 2020.
0 funds tracked by Wall St. Rank held Momenta Pharmaceuticals, Inc. as of Q4 2020.

Based on Pacer Advisors's 13F filing for Q4 2020, filed 20 Jan 2021.